ShiraTronics Raises $66M in Series B Funding for Chronic Migraine Treatment Development
ShiraTronics, a medical device company developing neurostimulation therapy for chronic migraine patients, has successfully closed a $66 million Series B financing round. The funding round was led by Norwest Venture Partners, with…
Read More from the Global Wellness News ™